Skip to main content
. Author manuscript; available in PMC: 2024 Aug 12.
Published in final edited form as: AIDS Behav. 2023 Dec 21;28(2):583–590. doi: 10.1007/s10461-023-04247-1

Table 3.

Outcomes associated with 3MMD in comparison to standard of care (< 3MMD) among clients receiving HIV care and treatment at selected facilities in Kenya, July 2017 – December 2019

Outcomes Unadjusted RR (95% CI) Adjusted RR (95% CI)
 LTFU 180 days** 1.2 (0.8–2.0) 1.1 (0.7–1.6)
 Viral rebound *** 0.1 (0.0–0.2) 0.1 (0.0–0.2)
*

Relative risk for LTFU 90 days was adjusted by sex, age at time of visit, model of care at time of entry into the cohort, ART regimen at time of outcome

**

Relative risk for LTFU 180 days was adjusted by sex, age at time of visit, ART regimen at time of outcome and location type (urban vs. rural)

***

Relative risk for viral rebound was adjusted by sex, age at time of visit, and previous switching between care models